Authors
Loading...
Analyses identify circulating T cell profiles and tumor microenvironment types linked to immune checkpoint blockade outcomes in sarcoma, suggesting personalized treatment strategies.
Rosenbaum et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: